Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma
Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop
tumor cells from growing. Combining biological therapies with indomethacin and
cyclophosphamide may kill more tumor cells.
PURPOSE: Phase II trial to compare the effectiveness of indomethacin and biological therapy
with or without cyclophosphamide in treating patients who have advanced melanoma that has not
responded to previous therapy.